Literature DB >> 10364289

Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines.

S Gummuluru1, M Emerman.   

Abstract

Viral protein R (Vpr) of human immunodeficiency virus type 1 (HIV-1) transiently arrests cells in the G2 phase of the cell cycle and is a weak transcriptional transactivator. We found that Vpr increased HIV-1 long terminal repeat (LTR) activity in all cells examined but, when expressed at high levels, decreased HIV-1 LTR expression due to cytotoxic effects. Moreover, Vpr-mediated enhancement of HIV-1 LTR-driven transcription was observed in cycling primary human CD4(+) T cells but not in terminally differentiated, noncycling primary human macrophages. In single-round infection experiments using primary human CD4(+) T cells, proviral clones expressing either wild-type Vpr or Vpr mutants that retained the ability to cause a G2 arrest replicated to higher levels than proviruses lacking Vpr or expressing mutants of Vpr that did not cause an arrest. In support of the hypothesis that enhancement of HIV-1 LTR transcription by Vpr is an indirect effect of the ability of Vpr to delay cells in G2, counterflow centrifugal elutriation of cells into different phases of the cell cycle demonstrated that HIV-1 LTR expression was highest in G2. Finally, the ability of Vpr to upregulate viral transcription was dependent on a minimal promoter containing a functional TATA box and an enhancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364289      PMCID: PMC112598     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Mitotic regulation of TFIID: inhibition of activator-dependent transcription and changes in subcellular localization.

Authors:  N Segil; M Guermah; A Hoffmann; R G Roeder; N Heintz
Journal:  Genes Dev       Date:  1996-10-01       Impact factor: 11.361

2.  Separation by counterflow centrifugal elutriation and analysis of T- and B-lymphocytic cell lines in progressive stages of cell division cycle.

Authors:  K L Donaldson; A McShea; A F Wahl
Journal:  J Immunol Methods       Date:  1997-04-11       Impact factor: 2.303

3.  Consistent transient transfection of DNA into non-transformed human and murine T-lymphocytes.

Authors:  R Q Cron; L A Schubert; D B Lewis; C C Hughes
Journal:  J Immunol Methods       Date:  1997-07-14       Impact factor: 2.303

4.  Conservation and host specificity of Vpr-mediated cell cycle arrest suggest a fundamental role in primate lentivirus evolution and biology.

Authors:  G L Stivahtis; M A Soares; M A Vodicka; B H Hahn; M Emerman
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

5.  Repression of RNA polymerase II and III transcription during M phase of the cell cycle.

Authors:  A Leresche; V J Wolf; J M Gottesfeld
Journal:  Exp Cell Res       Date:  1996-12-15       Impact factor: 3.905

6.  Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.

Authors:  S R Bartz; M A Vodicka
Journal:  Methods       Date:  1997-08       Impact factor: 3.608

7.  Human cytomegalovirus infection inhibits G1/S transition.

Authors:  D Dittmer; E S Mocarski
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

8.  S-phase-dependent cell cycle disturbances caused by Aleutian mink disease parvovirus.

Authors:  M B Oleksiewicz; S Alexandersen
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

9.  HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B.

Authors:  V Ayyavoo; A Mahboubi; S Mahalingam; R Ramalingam; S Kudchodkar; W V Williams; D R Green; D B Weiner
Journal:  Nat Med       Date:  1997-10       Impact factor: 53.440

10.  Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription.

Authors:  B E Sawaya; K Khalili; W E Mercer; L Denisova; S Amini
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

View more
  61 in total

1.  An in vitro rapid-turnover assay for human immunodeficiency virus type 1 replication selects for cell-to-cell spread of virus.

Authors:  S Gummuluru; C M Kinsey; M Emerman
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Viral protein U (Vpu)-mediated enhancement of human immunodeficiency virus type 1 particle release depends on the rate of cellular proliferation.

Authors:  A Deora; L Ratner
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Nuclear export of human immunodeficiency virus type 1 Vpr is not required for virion packaging.

Authors:  Y Jenkins; P V Sanchez; B E Meyer; M H Malim
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 Vpr contains two leucine-rich helices that mediate glucocorticoid receptor coactivation independently of its effects on G(2) cell cycle arrest.

Authors:  M P Sherman; C M de Noronha; D Pearce; W C Greene
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  HIV-1 Vif promotes the G₁- to S-phase cell-cycle transition.

Authors:  Jiangfang Wang; Emma L Reuschel; Jason M Shackelford; Lauren Jeang; Debra K Shivers; J Alan Diehl; Xiao-Fang Yu; Terri H Finkel
Journal:  Blood       Date:  2010-12-13       Impact factor: 22.113

6.  HIV-1 Vpr protein activates the NF-κB pathway to promote G2/M cell cycle arrest.

Authors:  Zhibin Liang; Ruikang Liu; Yongquan Lin; Chen Liang; Juan Tan; Wentao Qiao
Journal:  Virol Sin       Date:  2015-12-14       Impact factor: 4.327

7.  Vpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells.

Authors:  Ferdinand Roesch; Léa Richard; Réjane Rua; Françoise Porrot; Nicoletta Casartelli; Olivier Schwartz
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

8.  Cell cycle arrest in G2 induces human immunodeficiency virus type 1 transcriptional activation through histone acetylation and recruitment of CBP, NF-kappaB, and c-Jun to the long terminal repeat promoter.

Authors:  Sylvain Thierry; Vincent Marechal; Michelle Rosenzwajg; Michèle Sabbah; Gérard Redeuilh; Jean-Claude Nicolas; Joël Gozlan
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

9.  Proliferating cellular nuclear antigen expression as a marker of perivascular macrophages in simian immunodeficiency virus encephalitis.

Authors:  Kenneth Williams; Annette Schwartz; Sarah Corey; Marlene Orandle; William Kennedy; Brendon Thompson; Xavier Alvarez; Charlie Brown; Suzanne Gartner; Andrew Lackner
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

10.  Heat shock protein 70 protects cells from cell cycle arrest and apoptosis induced by human immunodeficiency virus type 1 viral protein R.

Authors:  Sergey Iordanskiy; Yuqi Zhao; Larisa Dubrovsky; Tatiana Iordanskaya; Mongzhong Chen; Dong Liang; Michael Bukrinsky
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.